Event Overview: Symposium on Healthy China and Biomanufacturing Industry Development
On the afternoon of 13 January, the symposium on "Healthy China and Biomanufacturing Industry Development" was held at the Xinhua News Agency National Financial Information Building. Jointly organised by the Xinhua Net Listed Companies Research Institute and Guosheng Think Tank, the event aimed to convene insights from think tanks, enterprises, academia, and capital markets to collectively explore biomanufacturing's pivotal role in advancing the Healthy China strategy and industrial upgrading. Representatives from think tanks, high-tech enterprises, university research institutes, and financial institutions engaged in in-depth discussions on topics including the integrated development of biomanufacturing and artificial intelligence, as well as pathways for industrial innovation.
Xinhuanet: Building a Cross-Sector Platform to Promote Industrial Integration
Qiu Xiaomin, Editorial Board Member of Xinhua Net and Executive Vice President of Xinhua Net Listed Companies Research Institute, stated in his address that as a strategic emerging industry, biomanufacturing represents a key domain for cultivating new productive forces and serves as vital support for advancing the Healthy China initiative. As a national mainstream media outlet, Xinhua Net will continue to focus on and promote the deep integration of industry with capital, technology with health, leveraging its role in guiding public discourse and connecting resources to facilitate high-quality development within China's biomanufacturing sector. He emphasised that this symposium represents a concrete practice in establishing a cross-sector dialogue platform, aiming to facilitate efficient coordination among policy, technology, capital and market forces.
Guosheng Think Tank: Launching Special Research on Biomanufacturing in 2026
Xu Yunfeng, Executive Director of Guosheng Think Tank, systematically outlined the think tank's efforts in advancing the construction of an innovation platform integrating artificial intelligence and biomedicine. He contended that confronting the new wave of technological revolution and industrial transformation necessitates enhanced top-level design and resource integration in frontier fields. Guosheng Think Tank has initiated relevant research projects and case studies, actively engaging with national high-end think tank resources to foster a collaborative innovation mechanism integrating "think tank + communication + industry". Xu specifically highlighted that in 2026, the think tank's research team will undertake a specialised study on future industrial biomanufacturing. This initiative aims to generate policy-relevant outcomes, which will be submitted to relevant authorities through authoritative journals and other channels, thereby providing intellectual support for industrial advancement.
APPCHEM: From Natural Extraction to AI-Driven Digital Nutrition
Hu Yongwei, Chairman of XI'AN APP-CHEM BIO (TECH) CO., Ltd., elaborated on the rationale and vision for transitioning from natural extraction to biomanufacturing based on corporate practice. He noted that traditional natural extraction faces constraints from raw material supply and cost pressures, whereas biomanufacturing employs synthetic biology techniques to substantially enhance product efficiency, reduce production costs, and achieve environmentally sustainable production. APPCHEM pursues "AI-driven digital nutrition" as its developmental direction, dedicated to deciphering natural substance compositions through artificial intelligence and constructing personalised nutritional intervention systems. This approach facilitates a leap in health management from "one size fits all" to "tailored for each individual". Hu Yongwei affirmed the company's commitment to increasing investment in bio-manufacturing, delivery systems, and digital platforms to propel the nutrition and health industry towards precision and intelligent upgrades.
Tsinghua Expert: Integration of AI and Biomanufacturing Accelerates R&D Innovation
Wu Zhuohao, Chief Scientific Advisor at the Art and Technology Innovation Design Centre of Shenzhen Tsinghua University Research Institute and Associate Professor at Communication University of China, analysed the immense potential of AI-biomanufacturing convergence through the lens of AI technological evolution. He highlighted that while AI has surpassed human capabilities in multiple specialised domains, it still requires collaboration with human experts for complex systems decision-making. Through the "AI Creativity" framework, artificial intelligence can achieve deep integration with domain knowledge, playing a greater role in scenarios such as drug development, nutritional design, and health management. Wu Zhuhao illustrated that advances in AI's multimodal understanding, image generation, and specialised research have provided novel tools for R&D innovation in the biomanufacturing field. This holds promise for significantly shortening development cycles and enhancing the efficiency of translating scientific research outcomes into practical applications in the future.
Financial Perspective: Capital Boosts the Commercialisation of Biomedicine
At the symposium, financial experts including Zhang Jizhe, Director of the M&A Department at China Securities and Investment Corporation and lead sponsor representative, and Wang Yuankai, Head of the Capital Markets Department at China Great Wall Asset Management Corporation, highlighted from a capital markets perspective that the biomanufacturing industry possesses high growth potential and strategic value, having become a key focus area for capital. They stated that through innovative financial products and services, they would support biomedicine enterprises possessing core technologies and promising market prospects to accelerate their listing, M&A, and industrialisation processes, thereby fostering a virtuous cycle among technology, industry, and capital. During the symposium, Xinhua Net's Listed Companies Research Institute and XI'AN APP-CHEM BIO (TECH) CO., Ltd., reached a consensus on advancing strategic cooperation, culminating in a brief signing ceremony. Participants unanimously agreed that cross-sector collaboration should be strengthened to establish an integrated ecosystem linking research, industry, capital and communication. This collective effort aims to secure a competitive edge for China's biomedicine manufacturing sector in the global arena, thereby injecting robust momentum into the Healthy China initiative and high-quality socio-economic development.
Source:
- Xinhua News Agency: https://www.news.cn/finance/20260115/80c1816e9b1f4eeba78ee51c04c84cfc/c.html
- Xi'an News Network: https://news4g.xiancity.cn/system/2026/01/15/031235694.shtml?_from=&_l=0&appId=&random=6e8a7dcd-fe41-43b0-80e0-8060bee9ff38&_c=2
- China.com: http://tcm.china.com.cn/m/2026-01/15/content_43335503.html
- Phoenix News: https://ishare.ifeng.com/c/s/v006rEkbiQ-_u3hrANdH2 --Y0Gpk7vBJij5lOLtBoSwhkzLoc2bjmh8AgUSycXAi4UbH50?spss=np&channelId=zhongdong&aman=fgg043Wr3rdfgY6g045MDYSxMjXAyMZjJh1ZmYKyMTJA21600v
- Strong Nation Channel: https://article.xuexi.cn/articles/index.html?art_id=17366957904553525815& item_id=17366957904553525815&study_style_id=feeds_opaque&study_comment_enable=1&study_comment_read_enable=0&favor_type=0&source=share&share_to=wx_single
- CCTV.com: https://gongyi.cctv.com/2026/01/15/ARTI0o3gklK2Ajffxud7AWl3260115.shtml Smart China: http://www.zhzgzz.com/xhtml/report/26010490-1.htm#10006-weixin-1-52626-6b3bffd01fdde4900130bc5a2751b6d1
About Xinhuanet, CCTV and China.com
- Xinhuanet, the flagship online platform of China's state news agency Xinhua, provides authoritative, multilingual news coverage from over 150 countries, serving as the trusted digital gateway for global readers to understand China.
- CCTV.com is the official website of China Central Television (CCTV), a state-designated key news website and part of the official national team of media.
- China.com was the first Chinese internet company to list on NASDAQ (1999). With state support, it has become a premier platform for global cultural exchange.